​FierceBiotech Executive Breakfast: Deciphering Immuno-Oncology, Trends in Deal-Making and R&D

Checkpoint inhibitors were a start for immunotherapies in cancer—but it's clear that the best way to manipulate the immune system to better defend against cancer is to intervene in multiple ways in the immune response pathway. Join FierceBiotech editor Ben Adams and a panel of experts as they examine the relative strengths and weaknesses of various strategies in development. Register today.